These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15540475)

  • 1. CMS panel examines states' challenges with Medicare reform.
    Young D
    Am J Health Syst Pharm; 2004 Aug; 61(16):1651-3. PubMed ID: 15540475
    [No Abstract]   [Full Text] [Related]  

  • 2. A bitter pill: the new Medicare prescription drug benefit.
    Siegel S
    Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
    [No Abstract]   [Full Text] [Related]  

  • 3. Inequality in health insurance reform: are the elderly more at risk?
    Phillips CR; Schuler DK; Jacobs EW
    J Health Care Mark; 1994; 14(4):14-9. PubMed ID: 10154632
    [No Abstract]   [Full Text] [Related]  

  • 4. An Rx for reform: a Medicare prescription drug benefit.
    Rak J
    Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
    Fise T
    Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle.
    Andersen LS
    Issue Brief Cent Medicare Educ; 2005; 5(10):1-10. PubMed ID: 15943013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare reforms receive mixed reaction. Bill is passed by Congress, but wrangling continues.
    Greenberg DS
    Lancet; 2003 Dec; 362(9400):1990. PubMed ID: 14686368
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 11. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare prescription drug/reform act: medicine chest or Pandora's box?
    Hager MH
    J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a rational, value-based drug benefit for Medicare.
    Lopert R; Moon M
    Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.
    West JC; Wilk JE; Muszynski IL; Rae DS; Rubio-Stipec M; Alter CL; Narrow WE; Regier DA
    Am J Psychiatry; 2007 May; 164(5):789-96. PubMed ID: 17475738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Siegel S
    Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 18. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?
    Gencarelli DM
    NHPF Issue Brief; 2002 Jun; (775):1-19. PubMed ID: 12083159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.
    Leonard CE; Brensinger CM; Nam YH; Bilker WB; Barosso GM; Mangaali MJ; Hennessy S
    BMC Health Serv Res; 2017 Apr; 17(1):304. PubMed ID: 28446159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.